Identification of gene signatures associated with response in a phase II trial of entinostat (ENT) plus pembrolizumab (PEMBRO) in non-small cell lung cancer (NSCLC) patients whose disease has progressed on or after anti-PD-(L)1 therapy Meeting Abstract
| Authors: | Ordentlich, P.; Wang, L.; Tamang, D.; Sullivan, A. H.; Church, S. E.; Rozelle, D.; Meyers, M. L.; Ramalingam, S. S.; Hellmann, M. D. |
| Abstract Title: | Identification of gene signatures associated with response in a phase II trial of entinostat (ENT) plus pembrolizumab (PEMBRO) in non-small cell lung cancer (NSCLC) patients whose disease has progressed on or after anti-PD-(L)1 therapy |
| Meeting Title: | 110th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 79 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2019 Mar 29-Apr 3 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2019-07-01 |
| Language: | English |
| ACCESSION: | WOS:000488129900036 |
| DOI: | 10.1158/1538-7445.Am2019-ct041 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CT041 -- Source: Wos |
